DiaMedica Therapeutics
Price & Volume
Stats
See moreOpen | $7.76 |
Previous Close | $7.63 |
Day Range | $7.64-$8.11 |
52W Range | $3.19-$7.68 |
Market Cap | $397.3M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.71 |
News
See moreYahoo Finance • 10 days ago
Microsoft initiated, Home Depot downgraded: Wall Street's top analyst calls
Yahoo Finance • 3 months ago
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge
Yahoo Finance • 4 months ago
DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares
Yahoo Finance • 4 months ago
DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock
About
CEO | Mr. Dietrich John Pauls MBA |
CFO | Mr. Scott Kellen CPA |
Address | 301 Carlson Parkway, Minneapolis, MN, United States, 55305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |
